The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

Lab-developed tests (LDTs) are laboratory tests where blood is drawn and placed in a test tube to help with identification, ...

On January 16, 2025, the U.S. Food and Drug Administration (“FDA”) published a highly anticipated proposed rule on front-of-package (“FOP”) ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

Researchers have developed a new chemical tool that could help lower the cost of prescription medications. The tool, called AshPhos, is a ligand, or molecule, that makes it easier to create special ...

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new ...

In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...

The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

Galapagos NV. announced its plans to split into two listed entities by mid-2025 by spinning off its activities focused on ...